Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin prophylaxis for infection prevention in myelodysplastic syndrome patients treated with azacitidine
MOH_2021-06-21_010067Phase 3Recruiting
- Sponsor
- דר ישי עופרן
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bacterial disease comparing Levofloxacin prophylaxis with Placebo prophylaxis (2 arms). Primary endpoint: Bacterial infection prevention. Started Jun 2021; status: recruiting.
02
Drugs
levofloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on MOH_2021-06-21_010067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-06-21_010067.